It's time to fight
antimicrobial resistance


Your Kit Contains:

  • Sample of Cutimed® Sorbact®
  • Infection Management and Prevention Product Literature
  • Antimicrobial Resistance Information

IN ORDER TO PREVENT...

...the spread of antimicrobial resistant bacteria there needs to be a significant decrease in antibiotic use in wound care.

While the World Health Organization is addressing AMR with a Global Action Plan, there is a lot of room to help to reduce AMR in the wound care sector.3 To be truly effective against AMR, action must be taken at every level of wound care, from wound specialists to wound nurses.

The European Wound Management Association recommends avoiding the unnecessary usage of antibiotics through adequate infection prevention/management and appropriate hygiene protocols.4

JOIN THE FIGHT AGAINST AMR

#WOUND_WARRIORS

THE WAY OF A WOUND WARRIOR

BECOME A WOUND WARRIOR AND JOIN THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE

With the right tools for infection prevention and management in wound care, the unnecessary use of antibiotics may be avoidable. Through its brands, Cutimed® and Leukomed®, Essity offers a comprehensive range of wound care products to help manage infection with no known risk of further contributing to antimicrobial resistance.

  • The purely physical mode of action of Sorbact® technology effectively binds and removes bacteria to help with the healing process
  • No known mechanism of resistance has been described
  • No additional release of endotoxins

FIGHT AGAINST AMR

APPROPRIATE WOUND CARE FOR INFECTION PREVENTION AND INFECTION MANAGEMENT CAN PLAY A POWERFUL ROLE IN THE FIGHT AGAINST AMR

Cutimed® and Leukomed® offer an extensive range of effective products in wound management and infection control which may help avoid excessive use of antibiotics in wound care.

SORBACT® TECHNOLOGY

Leukomed® Sorbact® and Cutimed® Sorbact® utilize the safe and effective Sorbact® technology that binds bacteria with a purely physical mode of action. Sorbact® Technology removes bacteria without releasing possibly harmful endotoxins.5

INFECTION MANAGEMENT WITH CUTIMED® SORBACT®

Advanced chronic wound dressing for safe and effective wound management with a purely physical mode of action.

SORBACT® BACTERIA-BINDING TECHNOLOGY
  • Safely binds bacteria and fungi
  • No known mechanism of resistance has been described

CUTIMED® SORBACT® HAS DEMONSTRATED PROVEN EFFECTIVENESS

In a randomized, comparative, single study of 40 patients with leg ulcers, Cutimed® Sorbact® was more effective at reducing bioburden than Aquacel® Ag.10

CUTIMED® SORBACT®

NEW NARRATIVE REVIEW SHOWS 4,044 PATIENTS WERE SUCCESFULLY TREATED IN CLINICAL STUDIES WITH SORBACT® TECHNOLOGY11
  • Wound infection prevention and management12 13 14
  • Purely physical mode of action
  • Binds bacteria and fungi15

#WOUND_WARRIORS

An antimicrobial stewardship initiative

INFECTION MANAGEMENT WITH LEUKOMED® SORBACT®

  • Clinically significant 65% relative risk reduction of acquiring a surgical site infection post caesarean section6
  • Up to 57% cost reduction when treating caesarean sections, using UK National Health Service Model (NHS) cost model7
  • Effective reduction of the bacterial burden in critically colonized or locally infected wounds8

Innovative surgical post-operative dressing for the reduction of bacterial colonization with a purely physical mode of action.

Indications

All post-operative and traumatic wounds with dry to low exudate levels:

  • Surgical incisions
  • Lacerations, cuts, abrasions

JOIN THE FIGHT AGAINST AMR

#WOUND_WARRIORS

STAND UP AGAINST AMR

WITH A WIDE RANGE OF PRODUCTS INCLUDING SORBACT® TECHNOLOGY FOR PREVENTION AND INFECTION MANAGEMENT IN WOUND CARE, FROM ESSITY

CUTIMED® SORBACT®
CUTIMED® SORBACT®

Infection management for chronic wounds with a purely physical mode of action

  • Sorbact® technology
  • No known mechanism of resistance has been described
  • Clinically effective
LEARN MORE
LEUKOMED® SORBACT®
LEUKOMED® SORBACT®

Surgical post-operative dressing for the reduction of bacterial colonization with a purely physical mode of action

  • Sorbact® bacteria-binding technology
  • Effective SSI prevention 6, 9
  • Adhesive film provides barrier to bacteria
LEARN MORE
CUTIMED® SILTEC® SORBACT®
CUTIMED® SILTEC® SORBACT®

The bacteria-binding silicone foam dressing for excellent fluid and infection management

  • Super-absorbent hot-melt stripes ensure vertical absorption of exudate reducing the risk of maceration
  • Dynamic MVTR allows fluid to transpire while also maintaining a moisture balance
  • Silicone layer minimizes pain with atraumatic dressing changes, and wound bed remains undisturbed
LEARN MORE
CUTIMED® SORBACT® HYDROACTIVE B
CUTIMED® SORBACT® HYDROACTIVE B

4-in-1: Absorb. Hydrate. Debride. Antimicrobial

  • Hydropolymer gel matrix helps maintain a moist wound environment
  • Stimulates autolytic debridement of fibrin and necrotic tissue
  • Helps prevent maceration
  • Ideal for absorption of thin exudate
LEARN MORE
CUTIMED® SORBION SORBACT®
CUTIMED® SORBION SORBACT®

Super absorbent dressing that also manages bacteria

  • High absorption capacity, long dressing wear time
  • Securely locks in exudate, even under compression
  • Maintains a moist wound environment by gel formation
LEARN MORE
LEUKOMED® CONTROL
LEUKOMED® CONTROL

Transparent wound dressing for effective infection risk control

  • Transparent, conformable film
  • Adhesive film provides barrier to bacteria
  • Skin-friendly adhesive
  • Absorbent hydropolymer gel
LEARN MORE

REFERENCES

  1. Fleming-Dutra, K., et al. (2016). “Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.” JAMA: The Journal of the American Medical Association 315(17): 1864-1873
  2. O’Neill, J. “Tackling drug-resistant infections globally: Final Report and Recommendations – The Review on Antimicrobial Resistance” May 2016
  3. World health Organization, Global Action plan on antimicrobial resistance, May 2015.
  4. EWMA document: Antimicrobials and Non-healing Wounds.
  5. As shown in vitro; Susilo YB, Husmark J. DACC Coated. Wound Dressing and Endotoxin: Investigation on Binding Ability and Effect on Endotoxin Release from Gram-negative Bacteria. Poster presented at EWMA 2019.
  6. Stanirowski J, Bizon M, Cendrowski K, et al (2016b) Randomized controlled trial evaluating dialkylcarbomyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing caesarean section. Surg Infect (Larchmt) 17(4): 427 -35.
  7. Stanirowski PJ, Davies H, McMaster J, Mealing S, Sawicki W, Cendrowski K, Posnett J. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. J Wound Care. 2019 Apr 2;28(4):222-228.
  8. Cutting K, Maguire J (2015) Safe bioburden management. A clinical review of DACC technology. Journal of Wound Care Vol 24, No 5.
  9. Bua N, et al. Dlalkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct:44:387-392.
  10. Mosti et al., Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study, Journal of Wound Care, 2015 Mar;24(3):121-2; 124-7.
  11. Chadwick and Ousey Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review journal of wound care Vol 28, No 6, June 2019.
  12. Mosti et al., (2015) “Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study”, Journal of Wound Care, 24(3): 121-2; 147-7.
  13. Stanirowski et al. Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Surg Infect (Larchmt). 2016 Aug;17(4):427-35.
  14. Totty et al., Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review, Vol 26, No 3, March 2017.
  15. Llungh et al Using the principle of hydrophobic interaction to bind and remove wound bacteria, Journal of Wound Care Vol 15, No 4, April 2006

Contact information

BSN Medical Inc., an Essity Company
5825 Carnegie Blvd.
Charlotte, NC 28209-4633
United States

Tel : 1-704-554-9933
Fax : 1-800-835-4325
To order toll-free: Tel. 1-800-537-1063

[email protected]

Social media